Investor CPMG Inc
13D/G Filings

This page shows a list of all the recent 13D/G filings made by CPMG Inc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2024-05-22 13D/A PRCT / PROCEPT BioRobotics Corporation 3,780,460 1,770,407
2024-05-07 13D/A PRCT / PROCEPT BioRobotics Corporation 5,674,405 3,780,460
2023-09-28 13D/A RETA / Reata Pharmaceuticals Inc - Class A 5,020,431 0
2023-08-01 13D/A RETA / Reata Pharmaceuticals Inc - Class A 5,030,056 5,020,431
2023-04-05 13D/A APEN / Apollo Endosurgery Inc 6,183,603 0
2022-12-30 13D/A APEN / Apollo Endosurgery Inc 6,077,397 6,183,603
2022-12-07 13D/A PRCT / PROCEPT BioRobotics Corporation 7,420,552 5,674,405
2022-11-16 13D/A PRCT / PROCEPT BioRobotics Corporation 9,246,425 7,420,552
2022-09-13 13D/A PRCT / PROCEPT BioRobotics Corporation 10,298,232 9,246,425
2022-09-08 13D/A PRCT / PROCEPT BioRobotics Corporation 11,388,191 10,298,232
2021-10-19 13D/A APEN / Apollo Endosurgery Inc 5,138,505 6,077,397
2021-09-27 13D PRCT / PROCEPT BioRobotics Corporation 11,388,191
2021-04-01 13D TIL / Instil Bio, Inc. 8,530,790
2021-02-17 13G/A GSS / Golden Star Resources Ltd. 10,767,905 0
2021-02-16 13G/A GSS / Golden Star Resources Ltd. 10,124,584 10,767,905
2020-12-30 13D/A RETA / Reata Pharmaceuticals Inc - Class A 5,030,056 5,030,056
2020-12-30 13D/A RETA / Reata Pharmaceuticals Inc - Class A 5,030,056 5,030,056
2020-12-29 13D/A RETA / Reata Pharmaceuticals Inc - Class A 5,028,787 5,030,056
2020-09-10 13D/A APEN / Apollo Endosurgery Inc 5,244,128 5,138,505
2020-07-22 13D/A APEN / Apollo Endosurgery Inc 3,406,965 5,244,128
2020-02-14 13G/A GSS / Golden Star Resources Ltd. 7,961,259 10,124,584
2019-08-14 13D/A APEN / Apollo Endosurgery Inc 1,272,349 3,406,965
2019-02-14 13G GSS / Golden Star Resources Ltd. 7,961,259
2018-07-31 13D/A RETA / Reata Pharmaceuticals Inc - Class A 5,018,943 5,028,787
2017-12-29 13D/A RETA / Reata Pharmaceuticals Inc - Class A 4,774,743 5,018,943
2017-11-13 13D/A RETA / Reata Pharmaceuticals Inc - Class A 4,774,743 4,774,743
2017-08-03 13D/A RETA / Reata Pharmaceuticals Inc - Class A 4,774,743 4,774,743
2017-07-27 13D/A APEN / Apollo Endosurgery Inc 817,804 1,272,349
2017-06-26 13D/A RETA / Reata Pharmaceuticals Inc - Class A 4,774,743 4,774,743
2017-06-23 13D/A RETA / Reata Pharmaceuticals Inc - Class A 3,556,785 4,774,743
2017-03-06 13D/A RETA / Reata Pharmaceuticals Inc - Class A 3,556,785 3,556,785
2017-01-09 13D APEN / Apollo Endosurgery Inc 817,804
2017-01-04 13D/A RETA / Reata Pharmaceuticals Inc - Class A 3,547,393 3,556,785
2016-12-20 13D/A RETA / Reata Pharmaceuticals Inc - Class A 3,373,751 3,547,393
2016-12-06 13D/A RETA / Reata Pharmaceuticals Inc - Class A 3,373,751 3,373,751
2016-08-19 13D/A RETA / Reata Pharmaceuticals Inc - Class A 3,065,531 3,373,751
2016-08-09 13D/A RETA / Reata Pharmaceuticals Inc - Class A 2,263,531 3,065,531
2016-07-01 13D/A RETA / Reata Pharmaceuticals Inc - Class A 2,098,931 2,263,531
2016-06-28 13D/A RETA / Reata Pharmaceuticals Inc - Class A 2,001,308 2,098,931
2016-06-06 13D RETA / Reata Pharmaceuticals Inc - Class A 2,001,308